For an upcoming FDA advisory committee meeting, the agency is questioning whether J&J, Pfizer and Roche have provided convincing clinical data for their cancer drugs in the right patient populations. More: Weighing approval bids from J&J, Pfizer and Roche, FDA
read moreIn a new public-private partnership, the Department of Health and Human Services and DARPA are linking up with several universities and companies in a bid to improve manufacturing for essential medicines in the U.S. using artificial intelligence, machine learning and
read moreThe FDA has lifted its 19-month clinical hold on vaginal yeast infection drug Brexafemme (ibrexafungerp), according to the treatment’s developer Scynexis. More: After 19 months, FDA lifts clinical hold on vaginal yeast infection drug Brexafemme Source: fierce
read moreCraig Romanok, chief marketing officer of Omnicom’s health-focused arm, shared his departure plans in a LinkedIn post Wednesday afternoon. More: With marketing chief's departure, Omnicom Health loses another exec ahead of Interpublic merger Source: fierce
read moreThe sale allows WuXi Biologics to solely focus on its Singapore capacities while marking the first step in Terumo’s global expansion. More: WuXi Biologics slims down again, handing off German plant to CDMO Terumo for 7M Source: fierce
read more© 1994 - 2025 B.M. Pharmaceuticals